Literature DB >> 11331323

Determinants of the use of complementary therapies by patients with cancer.

O Paltiel1, M Avitzour, T Peretz, N Cherny, L Kaduri, R M Pfeffer, N Wagner, V Soskolne.   

Abstract

PURPOSE: We performed a survey of Israeli oncology patients to examine the extent of their use of complementary therapies (CT) and to compare sociodemographic, psychologic, and medical characteristics, attitudes, and quality of life of users and nonusers of CT. PATIENTS AND METHODS: Questionnaires were administered to 1,027 patients attending ambulatory and inpatient hematology or oncology facilities at three hospitals. Medical information was extracted from charts. Univariate and multivariate comparisons of users and nonusers of CT were performed.
RESULTS: A total of 526 participants (51.2%) had used CT since their diagnosis, and 357 patients (34.9%) had used CT recently (in the past 3 months). Factors that multivariate analysis found to be significantly associated (P <.05) with recent CT use were as follows: female sex; age 35 to 59 years; more education; coming to the hospital by private car; advanced disease status; having a close friend or a relative with cancer; and attending support groups or individual counseling. After controlling for these factors, individually examined psychosocial variables associated with recent CT use included the following (odds ratios [OR] with 95% confidence intervals [CI]): needs unmet by conventional medicine (OR, 2.76; 95% CI, 1.95 to 3.89); helplessness (OR, 1.39; 95% CI, 1.0 to 1.91); incomplete trust in the doctor (OR, 1.49; 95% CI, 1.08 to 2.06); and changed outlook or beliefs since the diagnosis of cancer (OR, 1.47; 95% CI, 1.07 to 2.02). Functional quality of life (including physical, emotional, social, and role function) and symptom (fatigue and diarrhea) scores were significantly worse for recent CT users compared with nonusers, controlling for age, sex, and current disease status.
CONCLUSION: Characteristics associated with CT use include age, sex, education, and advanced disease. Significant associations between CT use and attending supportive psychotherapy, unmet needs, helplessness, and worse emotional and social function indicate considerable distress, suggesting that increased attention to psychosocial needs within oncologic settings is warranted.

Entities:  

Mesh:

Year:  2001        PMID: 11331323     DOI: 10.1200/JCO.2001.19.9.2439

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  56 in total

1.  Practitioners' sources of clinical information on complementary and alternative medicine in oncology.

Authors:  Michael Joseph Dooley; Diana Yu-Lin Lee; Jennifer Lillian Marriott
Journal:  Support Care Cancer       Date:  2003-12-04       Impact factor: 3.603

2.  Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations.

Authors:  Marion M Lee; Jeffrey S Chang; Bradly Jacobs; Margaret R Wrensch
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

3.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

4.  Integration of complementary medicine in supportive cancer care: survey of health-care providers' perspectives from 16 countries in the Middle East.

Authors:  Eran Ben-Arye; Elad Schiff; Kamer Mutafoglu; Suha Omran; Ramzi Hajjar; Haris Charalambous; Tahani Dweikat; Ibtisam Ghrayeb; Gil Bar Sela; Ibrahim Turker; Azza Hassan; Esmat Hassan; Ariela Popper-Giveon; Bashar Saad; Omar Nimri; Rejin Kebudi; Jamal Dagash; Michael Silbermann
Journal:  Support Care Cancer       Date:  2015-01-24       Impact factor: 3.603

Review 5.  Complementary and alternative medicine (CAM) in Mexican patients with cancer.

Authors:  Raquel Gerson-Cwilich; Alberto Serrano-Olvera; Alberto Villalobos-Prieto
Journal:  Clin Transl Oncol       Date:  2006-03       Impact factor: 3.405

6.  Changes in complementary and alternative medicine use across cancer treatment and relationship to stress, mood, and quality of life.

Authors:  Duck-Hee Kang; Traci McArdle; Yeonok Suh
Journal:  J Altern Complement Med       Date:  2014-10-24       Impact factor: 2.579

7.  Biologically based therapies are commonly self-prescribed by Brazilian women for the treatment of advanced breast cancer or its symptoms.

Authors:  Ana Camila Callado Alfano; Carlos Eduardo Paiva; Fernanda Capella Rugno; Raquel Haas da Silva; Bianca Sakamoto Ribeiro Paiva
Journal:  Support Care Cancer       Date:  2013-12-17       Impact factor: 3.603

8.  National survey of US oncologists' knowledge, attitudes, and practice patterns regarding herb and supplement use by patients with cancer.

Authors:  Richard T Lee; Andrea Barbo; Gabriel Lopez; Amal Melhem-Bertrandt; Heather Lin; Olufunmilayo I Olopade; Farr A Curlin
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

9.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

10.  Abnoba-viscum (mistletoe extract) in metastatic colorectal carcinoma resistant to 5-fluorouracil and leucovorin-based chemotherapy.

Authors:  Gil Bar-Sela; Nissim Haim
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.